Market Research Report
Medical Membrane Devices: Markets and Technologies
|Published by||BCC Research||Product code||228060|
|Published||Content info||116 Pages
Delivery time: 1-2 business days
|Medical Membrane Devices: Markets and Technologies|
|Published: March 1, 2019||Content info: 116 Pages||
The global market for medical membrane devices should grow from $28.6 billion in 2018 to $36.5 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
U.S. market for medical membrane devices should grow from $11.2 billion in 2018 to reach $14.4 billion by 2023 at a CAGR of 5.0% for the period of 2018-2023.
Asia-Pacific market for medical membrane devices should grow from $5.0 billion in 2018 to reach $6.9 billion by 2023 at a CAGR of 6.6% for the period of 2018-2023.
The scope of this report encompasses key market analysis, market drivers, market constraints and also competitive developments and trends in the market. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. This report involves the medical membrane devices used in the medical device industry. This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices. The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home care diagnosis. It also covers details regarding healthcare spending and the U.S. healthcare system.
Excluded from this report are membranes employed in other facets of medicine. These applications and devices include hollow fiber bioreactors employed in the production of monoclonal antibodies, recombinant proteins and drugs, nonseparating membranes used in drug-delivery systems, tissue scaffolding and synthetic skin. In addition, experimental artificial organs (e.g., liver, pancreas, implanted lung); apheresis filtration for stem cell recovery, virus filters and other cross-flow filters used in the production of pharmaceuticals; and blotting membranes (excluding their application in diagnostics) will not be considered in this report.